InDevR Licenses FDA Influenza Antibodies
InDevR Licenses FDA Influenza Antibodies for VaxArray™ InDevR’s access to [...]
InDevR Licenses FDA Influenza Antibodies for VaxArray™ InDevR’s access to [...]
InDevR participated in the recent ISIRV Options IX Conference. In addition to [...]
InDevR CEO, Dr. Kathy Rowlen, has contributed an opinion piece [...]
InDevR Launches Enhanced Flu Vaccine Potency Assay for All Stages [...]
Did You Miss the Free Flu-ToC (now VaxArray Influenza) Webinar? - [...]